Establishing a second-generation artificial intelligence-based system for improving diagnosis, treatment, and monitoring of patients with rare diseases-Reference-Cited by-同舟云学术

Establishing a second-generation artificial intelligence-based system for improving diagnosis, treatment, and monitoring of patients with rare diseases

Published:2021-07-19 Issue:10 Volume:29 Page:1485-1490
ISSN:1018-4813
Container-title:European Journal of Human Genetics
language:en
Short-container-title:Eur J Hum Genet

Author:

Hurvitz Noa,Azmanov Henny,Kesler Asa,Ilan Yaron^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Genetics

Link

https://www.nature.com/articles/s41431-021-00928-4.pdf

Reference71 articles.

1. Dementia—caring, ethics, ethnical and economical aspects: a systematic review. SBU System Rev. 2008.

2. Faviez C, Chen X, Garcelon N, Neuraz A, Knebelmann B, Salomon R, et al. Diagnosis support systems for rare diseases: a scoping review. Orphanet J rare Dis. 2020;15:1–16.

3. Villalon-Garcia I, Alvarez-Cordoba M, Suarez-Rivero JM, Povea-Cabello S, Talaveron-Rey M, Suarez-Carrillo A, et al. Precision medicine in rare diseases. Diseases. 2020;8.

4. Faviez C, Chen X, Garcelon N, Neuraz A, Knebelmann B, Salomon R, et al. Diagnosis support systems for rare diseases: a scoping review. Orphanet J Rare Dis. 2020;15:94.

5. Lee CE, Singleton KS, Wallin M, Faundez V. Rare genetic diseases: nature’s experiments on human development. iScience. 2020;23:101123.

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming Low Adherence to Chronic Medications by Improving their Effectiveness using a Personalized Second-generation Digital System;Current Pharmaceutical Biotechnology;2024-12

2. Artificial Intelligence and Machine Learning for Inborn Errors of Immunity: Current State and Future Promise;The Journal of Allergy and Clinical Immunology: In Practice;2024-08

3. Improving the response to lenvatinib in partial responders using a Constrained-Disorder-Principle-based second-generation artificial intelligence-therapeutic regimen: a proof-of-concept open-labeled clinical trial;Frontiers in Oncology;2024-07-30

4. Free Will as Defined by the Constrained Disorder Principle: a Restricted, Mandatory, Personalized, Regulated Process for Decision-Making;Integrative Psychological and Behavioral Science;2024-06-20

5. Artificial Intelligence Needs Data: Challenges Accessing Italian Databases to Train AI;Asian Bioethics Review;2024-06-13